You.ay not notice any changes in your vision. If you have any questions at any time after cataract surgery, call your eye doctor for advice. Cataract glasses were used for decades when there were no other options for lens replacement. An Updated Examination Of Strategies Of Cataracts | Guidance For The EyeAlthough no means of preventing cataracts has been scientifically proven, wearing ultraviolet protecting sunglasses may slow the development. 33 34 While regular intake of antioxidants such as vitamins A, C, and E has been thought to protect against the risk of cataracts, clinical trials have shown it does not. 35 Evidence is mixed, but weakly positive, for a potential protective effect of the nutrients’ lute in and zeaxanthin . 36 Stalin use is somewhat associated with a lower risk of nuclear sclerotic cataract. 37 Main article: Cataract surgery, using a temporal-approach phacoemulsification probe in right hand and “chopper” in left hand being done under operating microscope at a navy medical canter Slit lamp photo of posterior capsular pacification visible a few months after implantation of intra ocular lens in eye, seen on retro illumination Cataract removal can be performed at any stage and no longer requires ripening of the lens. A cataract may not need to be removed right away if your lifestyle isn’t significantly affected. The lens can then no longer transmit a clear picture to the retina where it can be processed and sent through the optic nerve to the brain. More than 180,000 cataract operations are performed every year. Cataract surgery is safe and effective. These Include Decreasing Patient Morbidity By Shortening The Course Of The Disease, Reducing Person-to-person Spread, Lowering The Risk Of Sight-threatening Complications Such As Corneal Ulceration, And Eliminating The Risk Of More Widespread Extra Ocular Disease. | Suggestions For Your EyesThen your doctor will determine how much eyesight has improved before surgery is done on the second eye.
The Wall Street Journal earlier reported that Abbott was in talks to sell the business to J&J. “We’ve been actively and strategically shaping our portfolio, which has recently focused on developing leadership positions in cardiovascular devices and expanding diagnostics,” Abbott Chief Executive Miles White said. The Alere deal has run into rough weather with the target company filing a lawsuit in August, accusing Abbott of dragging its feet on key antitrust submissions to sabotage the deal. To make matters worse, St. Jude is facing allegations that its pacemakers and defibrillators have cyber security flaws that hackers could exploit to harm patients. The company has sued short-selling firm Muddy Waters and cyber security firm MedSec Holdings Inc who raised the allegations. Wells Fargo analysts said Abbott was likely selling the eye care business because it was less of a strategic fit once it acquired St Jude and the company would need to reduce debt after the two deals. Abbott had long-term debt of about $6 billion as of June 30. For Johnson & Johnson, the deal would help expand its eye care portfolio with products in cataract surgery, laser refractive surgery and consumer eye health units.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/j-j-buy-abbotts-eye-191433560.html